Northern Trust Corp Alx Oncology Holdings Inc Transaction History

Northern Trust Corp

  • $709 Billion
  • Q2 2025

A detailed history of Northern Trust Corp transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Northern Trust Corp holds 135,909 shares of ALXO stock, worth $207,940. This represents 0.0% of its overall portfolio holdings.

Number of Shares
135,909
Previous 318,183 57.29%
Holding current value
$207,940
Previous $197,000 71.07%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
SELL
$0.41 - $0.61 $74,732 - $111,187
-182,274 Reduced 57.29%
135,909 $57,000
Q1 2025

May 13, 2025
SELL
$0.62 - $1.86 $15,427 - $46,282
-24,883 Reduced 7.25%
318,183 $197,000
Q4 2024

Feb 14, 2025
BUY
$1.21 - $1.87 $28,222 - $43,615
23,324 Added 7.29%
343,066 $572,000
Q3 2024

Nov 13, 2024
BUY
$1.81 - $8.13 $136,095 - $611,302
75,191 Added 30.75%
319,742 $581,000
Q2 2024

Aug 14, 2024
SELL
$5.84 - $17.56 $3,860 - $11,607
-661 Reduced 0.27%
244,551 $1.47 Million
Q1 2024

May 14, 2024
BUY
$10.95 - $16.79 $15,023 - $23,035
1,372 Added 0.56%
245,212 $2.73 Million
Q4 2023

Feb 13, 2024
BUY
$4.81 - $15.38 $251,639 - $804,620
52,316 Added 27.32%
243,840 $3.63 Million
Q3 2023

Nov 13, 2023
SELL
$4.19 - $7.35 $4,935 - $8,658
-1,178 Reduced 0.61%
191,524 $919,000
Q2 2023

Aug 11, 2023
SELL
$4.37 - $9.56 $25,586 - $55,973
-5,855 Reduced 2.95%
192,702 $1.45 Million
Q1 2023

May 15, 2023
SELL
$4.52 - $11.71 $19,770 - $51,219
-4,374 Reduced 2.16%
198,557 $897,000
Q4 2022

Feb 13, 2023
SELL
$9.51 - $12.95 $825,810 - $1.12 Million
-86,836 Reduced 29.97%
202,931 $2.29 Million
Q3 2022

Nov 14, 2022
BUY
$8.23 - $15.14 $738,897 - $1.36 Million
89,781 Added 44.89%
289,767 $2.77 Million
Q2 2022

Aug 12, 2022
BUY
$5.89 - $19.46 $154,859 - $511,642
26,292 Added 15.14%
199,986 $1.62 Million
Q1 2022

May 13, 2022
SELL
$13.65 - $22.06 $1,515 - $2,448
-111 Reduced 0.06%
173,694 $2.94 Million
Q4 2021

Feb 08, 2022
SELL
$21.49 - $74.4 $18,459 - $63,909
-859 Reduced 0.49%
173,805 $3.74 Million
Q3 2021

Nov 15, 2021
BUY
$52.51 - $80.91 $190,296 - $293,217
3,624 Added 2.12%
174,664 $12.9 Million
Q2 2021

Aug 13, 2021
SELL
$52.2 - $75.23 $261,522 - $376,902
-5,010 Reduced 2.85%
171,040 $9.35 Million
Q1 2021

May 12, 2021
BUY
$62.84 - $87.68 $3.52 Million - $4.91 Million
56,003 Added 46.65%
176,050 $13 Million
Q4 2020

Feb 11, 2021
BUY
$34.11 - $112.26 $144,319 - $474,972
4,231 Added 3.65%
120,047 $10.3 Million
Q3 2020

Nov 16, 2020
BUY
$29.36 - $47.1 $3.4 Million - $5.45 Million
115,816 New
115,816 $4.37 Million

Others Institutions Holding ALXO

# of Institutions
67
Shares Held
31.6M
Call Options Held
53.8K
Put Options Held
11.7K
View Full List

About ALX ONCOLOGY HOLDINGS INC

ALXO Quotes by TradingView
  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $62.3M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email